GREY:IMVIQ - Post by User
Comment by
bikkel78on Oct 31, 2018 2:52pm
![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
171 Views
Post# 28903111
RE:RE:Webcast
RE:RE:WebcastI got it confirmed, IMV is planning to meet with the FDA to discuss registration trial as a monotherapy. Huge achievement for the company because, as Fred Ord mentioned many times, DPX has better results than Keytruda!